Eustralis Pharmaceuticals Limited (trading as Pres
发明人:
VINK, Robert
申请号：
HK16108842.5
公开号：
HK1220639A
申请日:
2016.07.25
申请国别(地区):
HK
年份:
2017
代理人:
摘要：
The present invention relates to a method of preventing and/or treating chronic traumatic encephalopathy by administering to a subject N-(3,5-Bis-trifluoromethyl-benzyl)-N-methyl-6-(piperazin-1-yl)-4-o-tolyl nicotinamide or 4-alkyl-piperazin-1-yl derivatives thereof.
